Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Toshihiko Doi

Efficacy and Safety of TAS-116, an Oral Inhibitor of Heat Shock Protein 90, in Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumour Refractory to Imatinib, Sunitinib and Regorafenib: A Phase II, Single-Arm Trial

European Journal of Cancer

Cancer Research

Oncology

2019

English

Analysis of Esophagogastric Cancer Patients Enrolled in the National Cancer Institute Cancer Therapy Evaluation Program Sponsored Phase 1 Trials

English

First-In-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients With Advanced Solid Tumors

Molecular Cancer Therapeutics

Cancer Research

Oncology

2019

English

Clinicopathological Features of 22C3 PD-L1 Expression With Mismatch Repair, Epstein–Barr Virus Status, and Cancer Genome Alterations in Metastatic Gastric Cancer

English

Expression Profiles of HER2, EGFR, MET and FGFR2 in a Large Cohort of Patients With Gastric Adenocarcinoma

English

Phase I Study of Single-Agent Ribociclib in Japanese Patients With Advanced Solid Tumors

English

Phase I Study of TAS-102 and Irinotecan Combination Therapy in Japanese Patients With Advanced Colorectal Cancer

Investigational New Drugs

Oncology

Pharmacology

2015

English

A Phase I Study of Intravenous Aflibercept With FOLFIRI in Japanese Patients With Previously Treated Metastatic Colorectal Cancer

Investigational New Drugs

Oncology

Pharmacology

2012

English

Phase 1 Pharmacokinetic Study of MK-0646 (Dalotuzumab), an Anti-Insulin-Like Growth Factor-1 Receptor Monoclonal Antibody, in Combination With Cetuximab and Irinotecan in Japanese Patients With Advanced Colorectal Cancer

Cancer Chemotherapy and Pharmacology

English

A Retrospective Study of the Safety and Efficacy of Paclitaxel Plus Ramucirumab in Patients With Advanced or Recurrent Gastric Cancer With Ascites

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Toshihiko Doi

Efficacy and Safety of TAS-116, an Oral Inhibitor of Heat Shock Protein 90, in Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumour Refractory to Imatinib, Sunitinib and Regorafenib: A Phase II, Single-Arm Trial

Analysis of Esophagogastric Cancer Patients Enrolled in the National Cancer Institute Cancer Therapy Evaluation Program Sponsored Phase 1 Trials

First-In-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients With Advanced Solid Tumors

Clinicopathological Features of 22C3 PD-L1 Expression With Mismatch Repair, Epstein–Barr Virus Status, and Cancer Genome Alterations in Metastatic Gastric Cancer

Expression Profiles of HER2, EGFR, MET and FGFR2 in a Large Cohort of Patients With Gastric Adenocarcinoma

Phase I Study of Single-Agent Ribociclib in Japanese Patients With Advanced Solid Tumors

Phase I Study of TAS-102 and Irinotecan Combination Therapy in Japanese Patients With Advanced Colorectal Cancer

A Phase I Study of Intravenous Aflibercept With FOLFIRI in Japanese Patients With Previously Treated Metastatic Colorectal Cancer

Phase 1 Pharmacokinetic Study of MK-0646 (Dalotuzumab), an Anti-Insulin-Like Growth Factor-1 Receptor Monoclonal Antibody, in Combination With Cetuximab and Irinotecan in Japanese Patients With Advanced Colorectal Cancer

A Retrospective Study of the Safety and Efficacy of Paclitaxel Plus Ramucirumab in Patients With Advanced or Recurrent Gastric Cancer With Ascites